ResearchMoz

Indian Healthcare Industry

Publisher Name » Gyan Research And Analytics
Published Date » 2012-04-12
No. Of Pages » N/A

The report analyses the wide and diverse spectrum of Indian healthcare, with emphasis on opportunities in the areas of hospital infrastructure, pharmaceuticals, medical equipment, diagnostic labs and emerging fields like healthcare tourism, clinical trials & research, BPO in Healthcare and telemedicine.

SCOPE OF THE REPORT
  • Encompasses the entire healthcare manufacturing and services industry with their market 
  • size and share
  • Opportunities in various segments of the industry 
  • Outlook of the industry

KEY FEATURES DISCUSSED
  • Indian & Global market outlook 
  • Growth drivers and trends of the industry
  • Implications of the Union Budget 2012-13 on the industry
  • Emerging fields and their growth trends
  • Comparative Cost Advantage
  • Key Investments and M&A activities in respective segments
  • Export & Import of pharmaceuticals, healthcare products and medical equipment

WHY ONE SHOULD BUY
  • Comprehensive outlook of the industry
  • Detailed analysis of all the segments and their opportunities has been discussed
  • Better understanding of the market vis-à-vis market prospects
  • Better positioning of products and service
BENEFICIARIES OF THE REPORT
  • Pharmaceutical Companies and Healthcare Service Providers
  • Educational Institutes
  • Business Research, KPO & Consulting companies
  • Medical Equipment and Devices Manufacturers/Suppliers
  • IT & ITES in Healthcare Sector
  • Medical Practitioners & Clinical Trial Specialists
  • Government and Policy Makers
  • Commercial and Investment Banks
  • Individuals/Investors
Table of Contents

1. Executive Summary

2. Overview
2.1 Global Overview
2.2 Indian Overview

3. Indian Healthcare Industry
3.1 Market Size
3.2 Industry Structure
3.3 Market Segmentation and Trends
3.3.1 Healthcare Manufacturing
3.3.2 Healthcare-Services
3.4 Healthcare Infrastructure
3.5 Growth Drivers
3.6 Export-Import

4. Critical Success Factors

5. SWOT Analysis

6. Regulatory Norms

7. Cost Structure

8. Issues and Challenges

9. Opportunities

10. Investments
10.1 Domestic
10.2 Foreign Direct Investment (FDI)
10.3 Private Equity Investments
10.4 Key Mergers and Acquisitions (M&A)
11. Major Players
12. Outlook

List of Charts
Chart 1 – Historical Global Pharmaceutical Market Size
Chart 2 - Forecast of Global Pharmaceutical Industry (2011-15)
Chart 3 – Comparison of Global Expenditure on pharmaceuticals by Segments in 2010 & 2015
Chart 4 - Historical Indian Healthcare Market Size
Chart 5 – Forecast of Indian Healthcare Industry (2011-15)
Chart 6 – Segmentation of Indian Healthcare Market
Chart 7 – Comparison of Global Expenditure on Healthcare as a percent of GDP (2010)
Chart 8 - Comparison of Global Healthcare Expenditure (2010)
Chart 9 – Comparison of Global Per Capita Spending on PPP Basis
Chart 10 – Historical Indian Pharmaceutical Market Size
Chart 11 - Forecast of Indian Pharmaceutical Industry (2011-15)
Chart 12 - Segments of Indian Pharmaceutical Industry (2010)
Chart 13 – Historical Indian Medical Equipment Market Size
Chart 14 - Forecast of IndianMedical Equipment (2011-15)
Chart 15 - Historical Indian HospitalsMarket Size
Chart 16 - Forecast of IndianHospitals Industry(2011-15)
Chart 17 – Historical Allocation of India's Health Budget 
Chart 18 - Health Insurance Premium (FY2006-FY2011)
Chart 19 – Segmentation of Health Expenditure in India
Chart 20 -Indian Healthcare Delivery Structure
Chart 21 - India's GDP Growth Rate
Chart 22 - Indian Percentage Share in World's GDP
Chart 23 - BRIC’s Population growth Rate
Chart 24 – Comparison of Prevalence of Lifestyle Diseases in India (2005 & 2015)
Chart 25 – Life Expectancy in India (in Years)
Chart 26 - Export of Healthcare Products (FY2006-FY2011)
Chart 27 - Export of Medical Equipment (FY2006-FY2011)
Chart 28 - Import of Healthcare Products (FY2006-FY2011)
Chart 29 - Import of Medical Equipment (FY2006-FY2011)
Chart 30 – Medical Tourism Market in India (2009-2015)
Chart 31 – FDI Inflow in Healthcare in India (FY2006-FY2011)
Chart 32 – M&A Deals in Healthcare (2009-2011)

List of Tables


Table 1 - Top Five Drug Brands in the World by Sales
Table 2 - Major Investments in Biotechnology in India
Table 3 – Major Medical equipment Companies Details in India
Table 4 – Market Drivers for Health Insurance Sector in India
Table 5 - Major Pathological Labs’ Details in India
Table 6 – Comparison of Global Healthcare Infrastructure (2010)
Table 7 - Healthcare Infrastructure Indicators in India
Table 8 – SWOT Analysis of Indian Healthcare Industry
Table 9 – Cost Structure Comparison of Global Pharmaceutical Companies
Table 10 - Comparison of Key Healthcare Procedure Costs
Table 11 -Major PE Investments in Healthcare in India (2007-2010)
Table 12 – Value of M&A Deals in Healthcare in India (2007-2011)
Table 13 - MajorM&A Deals in Healthcare in India (2007-2010)
Table 14 – Financials of Apollo Hospitals Group (FY2006- FY2011)
Table 15 - Financials of Fortis Healthcare Group (FY2006- FY2011)
Table 16 - Financials of Piramal Healthcare (FY2006- FY2011)
Table 17- Financials of Ranbaxy Laboratories Ltd (FY2006- FY2011)
Table 18 - Financials of Dr Reddy’s Laboratories Ltd (FY2006- FY2011)
Table 19 - Financials of Sun Pharmaceuticals (FY2006- FY2011)

List of Figures


Figure 1: Indian Healthcare Industry Structure

Upcoming Reports:

Cement Additives Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
Cement additives are chemical formulations added to cement or concrete in small quantities to meet the design requirement and functional and aesthetic aspects of civil structures. These additives are used in residential, industrial, and commercial buildings. The major advantages of using additives include improved strength, color, chemical resistance, enhancement of cement properties and reduction in the use of other chemicals and water.  Cement additives can be segmented into mineral additives, chemical additives, and fiber additives. Mineral additives include silica...
Theranostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Theranostics is the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. Combination of medical drugs with diagnostic tests is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics market is an emerging field which is generating strong interest from healthcare industry and regulatory bodies. It is an emerging clinical diagnostics field that focuses on developing specific analysis to predict the use of most significant drug for patient. This technique uses molecular...
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global biologics market is estimated to reach $176.4 billion by the end of 2012 and expected to grow at an annual compound growth rate of more than 9.5%. In the U.S. the market will witness significant growth, due to a resolution passed by the U.S. lawmakers in 2010; There is increasing...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...